Table 2. Comparison of KIR3DL1/S1 allotypes in the presence or absence of their ligands within H1N1- confirmed ICU patients and St. Theresa aboriginals.
| ICU patients, Confirmed | |||
| KIR Allele | Ab | Nab | STh |
| 3DL1*00101 | |||
| Bw4+ | 5 (71.4%) | 5 (62.5%) | 37 (86.0%) |
| Bw6+, Bw4− | 2 (28.6%) | 3 (37.5%) | 6 (14.0%) |
| 3DL1*002 | |||
| Bw4+ | 0 (0%) | 4 (66.7%) | 1 (100%) |
| Bw6+, Bw4− | 0 (0%) | 2 (33.3%) | 0 (0%) |
| 3DL1*00501 | |||
| Bw4+ | 2 (66.7%) | 4 (66.7%) | 25 (69.4%) |
| Bw6+, Bw4− | 1 (33.3%) | 2 (33.3%) | 11 (30.6%) |
| 3DL1*01502 | |||
| Bw4+ | 4 (57.1%) | 5 (71.4%) | 15 (93.7%) |
| Bw6+, Bw4− | 3 (42.9%) | 2 (28.6%) | 1 (6.3%) |
| 3DS1*10 | |||
| Bw4+ | 1 (33.3%) | 0 (0%) | 5 (100%) |
| Bw6+, Bw4− | 2 (66.7%) | 0 (0%) | 0 (0%) |
| 3DS1*01301 | |||
| Bw4+ | 9 (90.0%) | 9 (75.0%) | 56 (77.8%) |
| Bw6+, Bw4− | 1 (10.0%) | 3 (25.0%) | 16 (22.2%) |
| 3DL1 | |||
| Bw4+ | 13 (72.2%) | 18 (64.3%) | 63 (79.8%) |
| Bw6+, Bw4− | 5 (27.8%) | 10 (35.7%) | 16 (20.3%) |
| 3DS1 | |||
| Bw4+ | 10 (76.9%) | 9 (75.0%) | 61 (79.2%) |
| Bw6+, Bw4− | 3 (23.1%) | 3 (25.0%) | 16 (20.8%) |
| 3DL1* | |||
| Bw4+ | 31 (67.4%) | 85 (81.0%) | |
| Bw6+, Bw4− | 15 (32.6%) | 20 (19.0%) | |
| 2DL2 | |||
| C1+ | 4 (66.7%) | 14 (100%) | 14 (45.2%) |
| C1−, C2+ | 2 (33.3%) | 0 (0%) | 17 (54.8%) |
| 2DL3 | |||
| C1+ | 13 (68.4%) | 30(100%) | 57 (54.3%) |
| C1−, C2+ | 6 (31.6%) | 0 (0%) | 48 (45.7%) |
| 2DL2/L3** | |||
| C1+ | 45 (88.2%) | 57 (54.3%) | |
| C1−, C2+ | 6 (11.8%) | 48 (45.7%) | |
Ab, Aboriginal; NAb, Non-aboriginal; STh, St. Theresa aboriginals.
**P<0.001, Pc<0.001.
*P<0.10.